Market Tracker

06/29 5:16pm ET

Trovagene Inc (NASDAQ:TROV)

4.53
Delayed Data
As of 4:00pm ET
 0.00 / 0.00%
Today’s Change
2.85
Today|||52-Week Range
10.46
-16.11%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close4.53
Today’s open4.59
Day’s range4.45 - 4.60
Volume205,857
Average volume (3 months)498,534
Market cap$135.3M
Dividend yield--
Data as of 4:00pm ET, 06/29/2016

Growth & Valuation

Earnings growth (last year)-37.50%
Earnings growth (this year)-21.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+11.65%
P/E ratioNM
Price/Sales456.64
Price/Book2.77

Competitors

 Today’s
change
Today’s
% change
VCYTVeracyte Inc-0.01-0.20%
LNTHLantheus Holdings In...+0.55+15.07%
OXFDOxford Immunotec Glo...-0.08-0.92%
CALACalithera Bioscience...-0.17-4.28%
Data as of 4:00pm ET, 06/29/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$312.8K
Annual profit (last year)-$27.5M
Net profit margin-8,781.98%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
William J. Welch
Chief Scientific Officer
Mark Erlander
Corporate headquarters
San Diego, California

Forecasts